Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 17, Pages 4300-4305
Publisher
Proceedings of the National Academy of Sciences
Online
2017-04-12
DOI
10.1073/pnas.1617709114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiolipins Are Biomarkers of Mitochondria-Rich Thyroid Oncocytic Tumors
- (2016) Jialing Zhang et al. CANCER RESEARCH
- Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens
- (2016) Mark Kriegsmann et al. MOLECULAR & CELLULAR PROTEOMICS
- Lipid and metabolite profiles of human brain tumors by desorption electrospray ionization-MS
- (2016) Alan K. Jarmusch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic pathways in T cell activation and lineage differentiation
- (2016) Luís Almeida et al. SEMINARS IN IMMUNOLOGY
- Pancreatic Cancer Surgical Resection Margins: Molecular Assessment by Mass Spectrometry Imaging
- (2016) Livia S. Eberlin et al. PLOS MEDICINE
- Activation of MEK1/2-ERK1/2 signaling during NNK-induced lung carcinogenesis in female A/J mice
- (2016) Keiko Yamakawa et al. Cancer Medicine
- Rapid Detection of Necrosis in Breast Cancer with Desorption Electrospray Ionization Mass Spectrometry
- (2016) Alessandra Tata et al. Scientific Reports
- Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis
- (2015) Patrick A. Carroll et al. CANCER CELL
- Increased phosphorylation of ERK1/2 is associated with worse chemotherapeutic outcome and a poor prognosis in advanced lung adenocarcinoma
- (2015) Ichiro Tsujino et al. Medical Molecular Morphology
- SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme
- (2015) C A Lewis et al. ONCOGENE
- MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
- (2015) Emelyn H. Shroff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade
- (2015) Ijeoma Adaku Umelo et al. Oncotarget
- In situ biomarker discovery and label-free molecular histopathological diagnosis of lung cancer by ambient mass spectrometry imaging
- (2015) Tiegang Li et al. Scientific Reports
- MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells
- (2015) Akriti Kharbanda et al. Oncotarget
- Alteration of the lipid profile in lymphomas induced by MYC overexpression
- (2014) L. S. Eberlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis
- (2014) David Calligaris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations
- (2014) Ahmet Yilmaz et al. International Journal of Environmental Research and Public Health
- Real-time nanoscale proteomic analysis of the novel multi-kinase pathway inhibitor rigosertib to measure the response to treatment of cancer
- (2013) Alice C Fan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress
- (2013) R. M. Young et al. GENES & DEVELOPMENT
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- MYC, Metabolism, Cell Growth, and Tumorigenesis
- (2013) C. V. Dang Cold Spring Harbor Perspectives in Medicine
- Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
- (2012) Joana Relat et al. BMC CANCER
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- KRAS Mutations in Lung Cancer
- (2012) Niki Karachaliou et al. Clinical Lung Cancer
- Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
- (2011) D. Gaglio et al. Molecular Systems Biology
- Fatty acid synthase as a potential therapeutic target in cancer
- (2010) Richard Flavin et al. Future Oncology
- Clinical Relevance of KRAS in Human Cancers
- (2010) Sylwia Jančík et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- A concise review of mass spectrometry imaging
- (2010) Erika R. Amstalden van Hove et al. JOURNAL OF CHROMATOGRAPHY A
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens
- (2009) Alice C Fan et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started